Efficacy of Tofacitinib in the Treatment of Psoriatic Arthritis: A Systematic Review.

Jordi Gratacos Carlos M González Fernández Susana Gómez Francisco Jose Rebollo Laserna

Published in: Advances in therapy (2020)

Tofacitinib has been demonstrated to be efficacious for the treatment of peripheral and axial involvement, enthesitis, and dactylitis manifestation in PsA. Further prospective and long-term studies are required to corroborate and complete the present results. Similarly, real-world evidence is also necessary to complement the information obtained in clinical trials, and thereby to have a better overview of real efficacy and safety of the drug.

Keyphrases

clinical trial
rheumatoid arthritis
prostate cancer
emergency department
combination therapy
systemic lupus erythematosus
health information
electronic health record
drug induced
adverse drug
double blind
placebo controlled